Depression and Anxiety Spectrum Disorders: From Basic Science to the Clinic and B

描述（由申请人提供）：2011年7月，我们计划在约旦安曼举办第一届中东会议，主题为“抑郁和焦虑谱系障碍：从基础科学到临床再回来”。康特中心和本次会议经费申请的首席研究员是罗彻斯特大学的Suzanne N. Haber博士。本次会议的执行委员会由以下中心成员组成：布朗大学巴特勒医院的Ben Greenberg博士；哈佛大学麻省总医院Darin Doughtery博士；哈佛大学-马萨诸塞总医院的Emad Eskandar医生、匹兹堡大学的Anthony Grace医生、哈佛大学-马萨诸塞总医院的Mohamed Milad医生和波多黎各大学的Greg Quirk医生。当地组委会包括：Munther hadadin和约旦大学医学院院长Azmi Mahafzah博士。之所以选择“抑郁和焦虑谱系障碍”这一主题，是因为我们与中东地区的临床医生和科学家进行了交谈，他们表达了兴趣和需求。执行委员会的成员由基础和临床科学家组成，代表了抑郁和焦虑谱系障碍临床方面及其生理学、解剖学和药理学的不同专业领域。因此，拟议的会议汇集了一组独特的临床和基础科学家，他们对这些疾病作为一个世界性问题特别感兴趣。第一次会议的目标是在文化多样化的环境中汇集抑郁症和焦虑谱系障碍的病理生理学和治疗专家，这些疾病普遍存在，但接触尖端研究的机会有限。我们将通过展示实验和治疗方法的数据来探索科学推动这一领域的新方向，以理解和治疗这些综合征。最后，我们将为该地区未来的研究和培训可能性制定一项议程，利用多名调查人员的多样性和专业知识。

DESCRIPTION (provided by applicant): In July 2011 we plan to hold our first Mideast conference on "Depression and Anxiety Spectrum disorders: from basic science to the clinic and back", in Amman, Jordan. The Principal Investigator for the Conte Center and this meeting grant application is Dr. Suzanne N. Haber, University of Rochester. The Executive Committee for this meeting consists of the following members of the Center: Dr. Ben Greenberg, Brown University-Butler Hospital; Dr. Darin Doughtery, Harvard University-Massachusetts General Hospital; Dr. Emad Eskandar Harvard University-Massachusetts General Hospital, Dr. Anthony Grace, University of Pittsburg, Dr. Mohamed Milad, Harvard University-Massachusetts General Hospital, and Dr. Greg Quirk, University of Puerto Rico. The local organizing committee includes, Drs. Munther Haddadin and Dr. Azmi Mahafzah, Dean of the Faculty of Medicine, University of Jordan. The topic, "depression and anxiety spectrum disorders", was chosen as a result of the expressed interests and needs of clinicians and scientists we spoke to in the Middle East. The members of the Executive Committee are a cross-section of basic and clinical scientists, representing different fields of expertise, in the clinical aspects of depression and anxiety spectrum disorders, and its physiology, anatomy, and pharmacology. The proposed meeting therefore brings together a unique group of clinical and basic scientists specifically interested in these diseases as a worldwide problem. The goal of this first meeting is to bring together experts on the pathophysiology and treatment of depression and anxiety spectrum disorders in a culturally diverse environment, where such disorders are prevalent, but exposure to cutting-edge research is limited. We will explore the new directions in which science is driving this field by presenting data on experimental and therapeutic approaches to understanding and treating these syndromes. Finally, we will lay out an agenda for future research and training possibilities in the region that draws upon the diversity and expertise of multiple investigators. PUBLIC HEALTH RELEVANCE: Depression and Anxiety Spectrum disorders are serious, dehabilitating mental health diseases that share common clinical features. These illnesses are under diagnosed and under treated in several Middle East countries. This topic of this meeting, "Depression and Anxiety Spectrum disorders: from basic science to the clinic and back" and venue (University of Jordan, Amman, Jordan), was chosen based on expressed interests and needs of clinicians and scientists in the Middle East. The goal of this US-led meeting is to bring experts into the region where such disorders are prevalent, but exposure to research is limited.